UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030055
Receipt number R000034317
Scientific Title VSB for unilateral conductive or mixed hearing loss
Date of disclosure of the study information 2017/11/21
Last modified on 2022/12/06 12:31:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

VSB for unilateral conductive or mixed hearing loss

Acronym

VSB for unilateral conductive or mixed hearing loss

Scientific Title

VSB for unilateral conductive or mixed hearing loss

Scientific Title:Acronym

VSB for unilateral conductive or mixed hearing loss

Region

Japan


Condition

Condition

Unilateral conductive hearing loss
Unilateral mixed hearing loss

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the clinical utility, safety, and effectiveness of VSB for unilateral conductive or unilateral mixed hearing loss cases.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The therapeutic effects are evaluated at 12 month after VSB surgely using free field audiometoly. 20dB or more threshold recovery regarded as effective cases.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Set the flowing mass transducer of VSB system on the round window by operation.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

4 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patient fulfill the below bone conduction hearing thresholds.
500Hz:45dB or less
1000Hz:50dB or less
2000Hz:65dB or less
4000Hz:65dB or less

Key exclusion criteria

1) Patients with highly malformation of cochlear or temporal bones.
2) Patients do not use general anesthesia.

Target sample size

5


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroaki Suzuki

Organization

Shinshu University School of Medicine

Division name

Department of Otorhinolaryngology

Zip code


Address

3-1-1 Asahi Matsumoto

TEL

0263-37-2666

Email

nishio@shinshu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shin-ya Nishio

Organization

Shinshu University School of Medicine

Division name

Department of Otorhinolaryngology

Zip code


Address

3-1-1 Asahi Matsumoto

TEL

0263-37-2666

Homepage URL


Email

nishio@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Shinshu University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

International University of Health and Welfar, Mita Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 06 Month 28 Day

Date of IRB

2016 Year 08 Month 17 Day

Anticipated trial start date

2016 Year 07 Month 09 Day

Last follow-up date

2021 Year 06 Month 03 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 11 Month 21 Day

Last modified on

2022 Year 12 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034317


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name